JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

Search

McKesson Corp

Abierto

SectorSalud

821.43 -3.25

Resumen

Variación precio

24h

Actual

Mínimo

812.69

Máximo

849.07

Métricas clave

By Trading Economics

Ingresos

426M

1.2B

Ventas

5.3B

103B

P/B

Media del Sector

26.453

84.243

Rentabilidad por dividendo

0.35

Margen de beneficio

1.173

Empleados

43,000

EBITDA

212M

1.5B

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 meses

+12.82% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.35%

2.28%

Próximas Ganancias

4 feb 2026

Fecha Próximo Dividendo

1 abr 2026

Próxima Fecha de Ex Dividendo

2 mar 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

3.3B

105B

Apertura anterior

824.68

Cierre anterior

821.43

Noticias sobre sentimiento de mercado

By Acuity

8%

92%

4 / 352 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bearish Evidence

McKesson Corp Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

3 feb 2026, 23:11 UTC

Principales Movimientos del Mercado
Adquisiciones, fusiones, absorciones

Silicon Laboratories Shares Up On Report of $7 Billion Texas Instruments Acquisition Deal

3 feb 2026, 23:50 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

3 feb 2026, 23:50 UTC

Charlas de Mercado

Nikkei May Decline After Hitting All-Time High -- Market Talk

3 feb 2026, 23:42 UTC

Charlas de Mercado

Gold Edges Lower on Possible Technical Correction -- Market Talk

3 feb 2026, 23:41 UTC

Adquisiciones, fusiones, absorciones

KKR Makes AI Play With $10.9B Asia Data-Center Deal

3 feb 2026, 23:38 UTC

Ganancias

AMD Sales Climb on Help From Data-Center Business -- Update

3 feb 2026, 23:29 UTC

Adquisiciones, fusiones, absorciones

KKR-Consortium Deal in STT GDC Is One of the Largest Digital-Infrastructure Transactions in Southeast Asia

3 feb 2026, 23:27 UTC

Adquisiciones, fusiones, absorciones

Netflix, Warner Defend Proposed Deal in Senate Hearing -- WSJ

3 feb 2026, 23:25 UTC

Adquisiciones, fusiones, absorciones

KKR-Consortium Expects Deal to Close by Early 2H of 2026

3 feb 2026, 23:23 UTC

Adquisiciones, fusiones, absorciones

KKR Consortium With Singtel to Own 75% and 25% Stake in ST Telemedia Global Data Centres

3 feb 2026, 23:22 UTC

Adquisiciones, fusiones, absorciones

KKR-Led Consortium to Buy Singapore-Based Global Data-Center Provider Valued at S$13.8B

3 feb 2026, 23:19 UTC

Charlas de Mercado

Australia Gold Miners Tipped to Rally Higher -- Market Talk

3 feb 2026, 23:19 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

3 feb 2026, 22:56 UTC

Principales Movimientos del Mercado
Adquisiciones, fusiones, absorciones

Silicon Laboratories Shares Up On Report of $7B Texas Instruments Acquisition Deal

3 feb 2026, 22:40 UTC

Ganancias

Amdocs Extends Collaboration With T-Mobile

3 feb 2026, 22:39 UTC

Ganancias

Amdocs 1Q Adj EPS $1.81

3 feb 2026, 22:39 UTC

Ganancias

Amdocs 1Q Rev $1.16B

3 feb 2026, 22:39 UTC

Ganancias

Amdocs 1Q EPS $1.45 >

3 feb 2026, 22:38 UTC

Ganancias

Amdocs: Shimie Hortig to Succeed Shuky Sheffer as President and CEO, Effective March 31

3 feb 2026, 22:30 UTC

Adquisiciones, fusiones, absorciones

Bob Iger's Second Time as CEO Wasn't Great for the Stock. He Still Leaves Behind A Strong Legacy. -- Barrons.com

3 feb 2026, 22:22 UTC

Adquisiciones, fusiones, absorciones

Texas Instruments Nearing $7B Deal for Silicon Laboratories, Sources Tell FT

3 feb 2026, 22:14 UTC

Ganancias

AMD Expects to Scale AI Business to Tens of Billions in Annual Sales in 2027, CEO Says

3 feb 2026, 22:13 UTC

Ganancias

AMD Expects Data-Center Unit Sales to Jump More Than 60% a Year Over Next Three to Five Years, CEO Says

3 feb 2026, 22:12 UTC

Ganancias

AMD in Talks With Several Companies About At-Scale, Multi-Year Chip Deployments, CEO Says

3 feb 2026, 22:10 UTC

Ganancias

AMD CEO: Eight of 10 Biggest AI Companies Use Instinct Chip to Power Production Workloads

3 feb 2026, 22:10 UTC

Ganancias

Blackstone Stock, Alternative Managers, BDCs Dive as Software Woes Infect Private Credit -- Barrons.com

3 feb 2026, 22:10 UTC

Charlas de Mercado

Key Drivers Underpinning Shaw's Bullish View of Gold Intact -- Market Talk

3 feb 2026, 22:10 UTC

Ganancias

AMD CEO: Enterprises Are Modernizing Data Centers to Have Compute Needed for New AI Workflows

3 feb 2026, 22:09 UTC

Ganancias

AMD CEO: Hyperscalers Expanding Infrastructure to Meet Growing Cloud-Services Demand in AI

3 feb 2026, 22:09 UTC

Ganancias

AMD CEO: Demand Accelerated Across Data Center, Gaming and PC

Comparación entre iguales

Cambio de precio

McKesson Corp Esperado

Precio Objetivo

By TipRanks

12.82% repunte

Estimación a 12 meses

Media 955 USD  12.82%

Máximo 1,000 USD

Mínimo 880 USD

De acuerdo con 11 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para McKesson Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

11 ratings

9

Comprar

2

Mantener

0

Vender

Puntuación técnica

By Trading Central

681.92 / 707.28Soporte y Resistencia

Corto Plazo

Strong Bearish Evidence

Medio plazo

No Evidence

Largo Plazo

No Evidence

Sentimiento

By Acuity

4 / 352 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat